FI873704A - Nya ksantinderivat. - Google Patents

Nya ksantinderivat. Download PDF

Info

Publication number
FI873704A
FI873704A FI873704A FI873704A FI873704A FI 873704 A FI873704 A FI 873704A FI 873704 A FI873704 A FI 873704A FI 873704 A FI873704 A FI 873704A FI 873704 A FI873704 A FI 873704A
Authority
FI
Finland
Prior art keywords
xantinderivat
nya
nya xantinderivat
Prior art date
Application number
FI873704A
Other languages
English (en)
Other versions
FI87356B (fi
FI873704A0 (fi
FI87356C (fi
Inventor
Zoltan L Kis
John Morley
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620825A external-priority patent/GB8620825D0/en
Priority claimed from GB878702129A external-priority patent/GB8702129D0/en
Priority claimed from GB878703435A external-priority patent/GB8703435D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI873704A0 publication Critical patent/FI873704A0/fi
Publication of FI873704A publication Critical patent/FI873704A/fi
Publication of FI87356B publication Critical patent/FI87356B/fi
Application granted granted Critical
Publication of FI87356C publication Critical patent/FI87356C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI873704A 1986-08-28 1987-08-26 Foerfarande foer framstaellning av nya xantinderivat FI87356C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8620825 1986-08-28
GB868620825A GB8620825D0 (en) 1986-08-28 1986-08-28 Organic compounds
GB8702129 1987-01-30
GB878702129A GB8702129D0 (en) 1987-01-30 1987-01-30 Organic compounds
GB878703435A GB8703435D0 (en) 1987-02-13 1987-02-13 Organic compounds
GB8703435 1987-02-13

Publications (4)

Publication Number Publication Date
FI873704A0 FI873704A0 (fi) 1987-08-26
FI873704A true FI873704A (fi) 1988-02-29
FI87356B FI87356B (fi) 1992-09-15
FI87356C FI87356C (fi) 1992-12-28

Family

ID=27263135

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873704A FI87356C (fi) 1986-08-28 1987-08-26 Foerfarande foer framstaellning av nya xantinderivat

Country Status (17)

Country Link
EP (1) EP0258191B1 (fi)
JP (1) JPH0631236B2 (fi)
KR (1) KR880002870A (fi)
AU (1) AU600021B2 (fi)
CA (1) CA1289954C (fi)
DE (1) DE3779374D1 (fi)
DK (1) DK169337B1 (fi)
ES (1) ES2033922T3 (fi)
FI (1) FI87356C (fi)
GR (1) GR3004747T3 (fi)
HU (1) HU199840B (fi)
IE (1) IE60512B1 (fi)
IL (1) IL83659A (fi)
MY (1) MY101830A (fi)
NZ (1) NZ221571A (fi)
PH (1) PH24761A (fi)
PT (1) PT85594B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020921D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
GB9210839D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
AU4527996A (en) 1994-12-13 1996-07-03 Euro-Celtique S.A. Trisubstituted thioxanthines
WO1996018399A1 (en) 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
EP1421084B1 (en) 2001-08-28 2008-05-14 Schering Corporation Polycyclic guanine phosphodiesterase v inhibitors
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1024968B (de) * 1956-03-31 1958-02-27 Asal Fabrik Biolog Und Pharmaz Verfahren zur Herstellung von 7-Ketonyl-8-amino-theophyllinen
AT212847B (de) * 1959-08-13 1961-01-10 Hans Dr Med Voigt Verfahren zur Herstellung des neuen Coffeino-(8)-(β-Phenyl-isopropyl)-amin
FR2157727A1 (en) * 1971-10-29 1973-06-08 Brun Lab Sa Le !,#dimethyl-8-aminopurines - with analgesicantitussive and other theophylline-like activities
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
DE3400951A1 (de) * 1984-01-13 1985-07-18 Robert Bosch Gmbh, 7000 Stuttgart Verfahren und vorrichtung zur drehzahlregelung bei einer brennkraftmaschine
HU197746B (en) * 1985-09-05 1989-05-29 Sandoz Ag Process for producing xantin derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0258191B1 (en) 1992-05-27
IL83659A0 (en) 1988-01-31
PT85594B (pt) 1990-05-31
HUT47111A (en) 1989-01-30
FI87356B (fi) 1992-09-15
IL83659A (en) 1991-06-10
GR3004747T3 (fi) 1993-04-28
JPH0631236B2 (ja) 1994-04-27
PT85594A (en) 1987-09-01
PH24761A (en) 1990-10-01
FI873704A0 (fi) 1987-08-26
JPS6363679A (ja) 1988-03-22
AU7744587A (en) 1988-03-03
MY101830A (en) 1992-01-31
IE60512B1 (en) 1994-07-27
DK169337B1 (da) 1994-10-10
ES2033922T3 (es) 1993-04-01
DK448787A (da) 1988-02-29
DK448787D0 (da) 1987-08-27
HU199840B (en) 1990-03-28
DE3779374D1 (en) 1992-07-02
FI87356C (fi) 1992-12-28
KR880002870A (ko) 1988-05-12
NZ221571A (en) 1990-11-27
EP0258191A1 (en) 1988-03-02
AU600021B2 (en) 1990-08-02
IE872296L (en) 1988-02-28
CA1289954C (en) 1991-10-01

Similar Documents

Publication Publication Date Title
FI873977A (fi) Nya (1h-imidazol-1-ylmetyl) substituerande bensimidazolderivat.
FI872878A (fi) Foerfarande foer framstaellning av nya algininsyraestrar.
FI874287A0 (fi) Nya lymfokinpeptider.
FI873704A0 (fi) Nya ksantinderivat.
FI871406A (fi) Foerfarande foer framstaellning av nya aminosyraderivat.
FI870871A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptidderivat.
FI875438A0 (fi) Foerfarande foer framstaellning av nya pyrrolobenzimidazoler.
FI873193A (fi) Nya 18-fenylestranderivat.
FI873593A0 (fi) Nya applikationsformer foer -interferon.
FI883257A0 (fi) Nya peptider.
FI872571A0 (fi) Nya antracykliner.
FI871094A0 (fi) Nya monocykliska estrar.
FI893155A0 (fi) Nya foereningar.
FI872489A (fi) Foerfarande foer framstaellning av nya aralkylimidazolderivat.
FI875766A (fi) Foerfarande foer framstaellning av nya pyrimidinderivat.
FI870626A0 (fi) Nya polymerbarriaerblandningar.
FI872735A0 (fi) Nya vacciner.
FI872527A0 (fi) Foerfarande foer framstaellning av nya peptider.
FI875130A (fi) Nya benzokinoliner.
FI870091A0 (fi) Nya biocider.
FI874885A (fi) Foerfarande foer framstaellning av nya kondenserade cykliska triazolderivat.
FI870872A (fi) Nya foereningar.
FI884633A0 (fi) Nya malonsyraderivatfoereningar.
FI860837A (fi) Nya alfa-aminoalkyl-alfa-alkylfenylacetonitriler.
FI862751A0 (fi) Nya makromolekyler.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: SANDOZ AG